Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

6.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.4K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

942
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
942
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome Mining Leads to the Discovery of Kasichelins A-D, Unusual β-Alanine- and β-Aminoisobutyric Acid-Containing Siderophores from <i>Streptomyces</i>.

Journal of natural products·2025
Same author

Multicolumn Two-Dimensional Liquid Chromatography Screening Platform for Stereopeptidomics and Application to Antimicrobial Peptide Polyene and Lipopeptide.

Analytical chemistry·2025
Same author

The TetR-like regulator Sco4385 and Crp-like regulator Sco3571 modulate heterologous production of antibiotics in <i>Streptomyces coelicolor</i> M512.

Applied and environmental microbiology·2025
Same author

The human microbiome-derived antimicrobial lugdunin self-regulates its biosynthesis by a feed-forward mechanism.

mBio·2025
Same author

The microbiome-derived antibacterial lugdunin acts as a cation ionophore in synergy with host peptides.

mBio·2024
Same author

Author Correction: Commensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus.

Nature microbiology·2024
Same journal

Successful treatment of rare non-dermatophyte onychomycosis caused by Chaetomium spp. with oral fluconazole and topical terbinafine combination - A case report from Indonesia and literature review.

International journal of medical microbiology : IJMM·2026
Same journal

Toxin gene truncation via IS1132 in non-toxigenic toxin gene-bearing (NTTB) Corynebacterium diphtheriae.

International journal of medical microbiology : IJMM·2026
Same journal

Gain-of-function mutation in the sensor kinase CpxS modulates the antimicrobial resistance and virulence of Pseudomonas aeruginosa.

International journal of medical microbiology : IJMM·2026
Same journal

Mycobacterium tuberculosis identification and antibiotic resistance gene profiling using nanopore sequencing: A new approach for tailoring more effective treatments for patients.

International journal of medical microbiology : IJMM·2026
Same journal

Epidemiology and population structure of Acinetobacter baumannii outbreak in a COVID-19 concentration center.

International journal of medical microbiology : IJMM·2026
Same journal

Herpes simplex virus 1 UL2 protein inhibits RIG-I-like receptor pathway-induced IFN-β activity by disrupting IRF3 activation.

International journal of medical microbiology : IJMM·2026
See all related articles

Related Experiment Video

Updated: Jan 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K

Caprazamycins: Biosynthesis and structure activity relationship studies.

Franziska Wiker1, Nils Hauck1, Stephanie Grond2

  • 1Pharmaceutical Biology, Pharmaceutical Institute, University of Tübingen, 72076 Tübingen, Germany.

International Journal of Medical Microbiology : IJMM
|May 30, 2019
PubMed
Summary
This summary is machine-generated.

Caprazamycins are novel liponucleoside antibiotics targeting the essential bacterial enzyme MraY translocase, crucial for cell wall biosynthesis. These compounds show promise against Mycobacterium species, offering a new avenue for antibacterial drug development.

Keywords:
CaprazamycinsMraY translocasePeptidoglycan biosynthesis

More Related Videos

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web
09:51

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Published on: July 16, 2017

16.0K
Juxtasomal Biocytin Labeling to Study the Structure-function Relationship of Individual Cortical Neurons
10:36

Juxtasomal Biocytin Labeling to Study the Structure-function Relationship of Individual Cortical Neurons

Published on: February 25, 2014

14.0K

Related Experiment Videos

Last Updated: Jan 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K
Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web
09:51

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Published on: July 16, 2017

16.0K
Juxtasomal Biocytin Labeling to Study the Structure-function Relationship of Individual Cortical Neurons
10:36

Juxtasomal Biocytin Labeling to Study the Structure-function Relationship of Individual Cortical Neurons

Published on: February 25, 2014

14.0K

Area of Science:

  • Microbiology and Biochemistry
  • Drug Discovery and Development
  • Synthetic Chemistry

Background:

  • Bacterial cell wall biosynthesis is a validated target for antibacterial agents.
  • MraY translocase, an essential integral membrane enzyme, is critical for peptidoglycan precursor lipid I formation.
  • Limited classes of compounds selectively inhibit MraY, highlighting the need for novel inhibitors.

Purpose of the Study:

  • To investigate caprazamycins as novel inhibitors of the MraY translocase.
  • To explore the antibacterial activity of caprazamycins, particularly against Mycobacterium species.
  • To understand the structural features and biosynthetic pathways of caprazamycins for structure-activity relationship studies.

Main Methods:

  • Isolation and structural elucidation of caprazamycins from Streptomyces sp. MK730-62F2.
  • In vitro testing of antibacterial activity against Gram-positive bacteria, including Mycobacterium tuberculosis.
  • Biosynthetic studies involving feeding experiments and genetic engineering of biosynthetic gene clusters.
  • Chemical synthesis for structure-activity relationship investigations.

Main Results:

  • Caprazamycins possess a unique (+)-caprazol core skeleton, shared with other MraY inhibitors.
  • They exhibit in vitro activity against Gram-positive bacteria, notably Mycobacterium species.
  • Studies revealed common initial biosynthetic steps and potential branching points for caprazamycins.
  • Structural modifications through various methods generated diverse caprazamycin analogs.

Conclusions:

  • Caprazamycins represent a promising class of liponucleoside antibiotics targeting MraY translocase.
  • Their activity against Mycobacterium species warrants further investigation for tuberculosis and other infections.
  • Understanding their biosynthesis and structure-activity relationships facilitates the development of new antibacterial agents.